APA (7th ed.) Citation

Y, L., X, H., J, Z., & S, Z. (2021). Role of CD5L and SRD5A2 as Prognostic Biomarkers for Hepatocellular Carcinoma. Dove Medical Press.

Chicago Style (17th ed.) Citation

Y, Luo, Huang X, Zhan J, and Zhang S. Role of CD5L and SRD5A2 as Prognostic Biomarkers for Hepatocellular Carcinoma. Dove Medical Press, 2021.

MLA (8th ed.) Citation

Y, Luo, et al. Role of CD5L and SRD5A2 as Prognostic Biomarkers for Hepatocellular Carcinoma. Dove Medical Press, 2021.